IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RXI Pharmaceuticals Corp New

CUSIP: 74979C808 | 24 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

Claro Advisors Inc.378
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Claro Advisors Inc.
378$00.0%CoreLowBoston, MA2019-02-14